Johnson & Johnson has agreed to pay nearly $117 million to resolve allegations that it deceptively marketed transvaginal surgical mesh devices, U.S. state attorneys general said on Thursday.
Latest posts by Reuters News (see all)
- Trump’s EU envoy Sondland faces grilling before impeachment hearing - November 20, 2019
- Highligts: Protesters in a Hong Kong university search for escape route - November 20, 2019
- Target lifts profit goal on expected holiday boost, shares surge - November 20, 2019